Kashyap Tele-Medicines Ltd
Ticker: KASHYAP
Risky
48/100
☆ Add to Watchlist
Investing Reference
Price
10.44
Market Cap
49.82
Debt/Equity
0.0000
ROE %
-4.580
PB
77.8465
Promoter %
61.930
Pledge %
0.000
1Y Rev Growth %
0.000
5Y Rev Growth %
-1.021
NP Margin %
0.000
NP Margin 5Y Avg %
-172.053
Trading Reference
1M Return %
1.458
6M Return %
53.304
1Y Return %
374.545
% Away 52W High
19.732
% Away 52W Low
630.070
Daily Volume
19799
Investment Verdict
Avoid
Score 37/100 · Position size: 0%
Fundamentals/valuations or risk flags are weak. Avoid for long-term investing.
Trading Verdict
Avoid
Score 34/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
Summary
Kashyap Tele-Medicines Ltd shows potential in the growing telemedicine sector, but faces competitive and regulatory challenges.
✅ Positives
- Strong growth in telemedicine demand
- Innovative technology solutions
- Experienced management team
⚠️ Negatives
- Intense market competition
- Regulatory hurdles in healthcare
- Dependence on technology infrastructure
Verdict
Cautiously optimistic about future growth.
Recommendation: Consider buying on dips.
Upside Probability: 30% | Downside Probability: 20%
Last generated: 30/10/2025
More Options
M
Mohit Paper Mills Ltd
Mohit Paper Mills Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
R
Relic Technologies Ltd
Relic Technologies Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
I
Integrity Infrabuild Developers Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
C
Challani Capital Ltd
Challani Capital Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
R
Roopa Industries Ltd
Roopa Industries Ltd shows potential but faces challenges in growth consistency and market sentiment.
View details
G
Gini Silk Mills Ltd
Gini Silk Mills Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
B
Baba Arts Ltd
Baba Arts Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
View details
N
Nippon India Silver ETF
Nippon India Silver ETF presents a decent investment opportunity, particularly for those looking to diversify into precious metals.
View details
S
Shashijit Infraprojects Ltd
Shashijit Infraprojects Ltd shows potential but faces several challenges that may hinder growth and profitability.
View details
R
Radiowalla Network Ltd
Radiowalla Network Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
J
JFL Life Sciences Ltd
JFL Life Sciences Ltd shows potential in a growing sector, but faces challenges in profitability and market sentiment.
View details
M
Monotype India Ltd
Monotype India Ltd shows potential but faces challenges in growth consistency and valuation metrics.
View details
E
Erp Soft Systems Ltd
While Erp Soft Systems Ltd operates in a promising sector, its inconsistent growth and profitability metrics suggest caution. The company has potential but faces significant execution risks.
View details
S
Siti Networks Ltd
Siti Networks Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
A
ANG Lifesciences India Ltd
ANG Lifesciences India Ltd shows potential for growth but faces challenges in profitability and valuation. Caution is advised.
View details
T
Travels & Rentals Ltd
Travels & Rentals Ltd operates in a promising sector, but faces significant challenges in growth consistency and profitability, making it a risky investment at this time.
View details
Business Overview
Kashyap Tele-Medicines Ltd is a pioneering healthcare provider specializing in telemedicine services across India. Designed for patients seeking convenient access to quality healthcare, it connects users with certified medical professionals through a secure digital platform. This innovative approach enhances healthcare accessibility, especially in remote areas, ensuring timely consultations and follow-ups. With a focus on patient-centric care, Kashyap is committed to improving health outcomes and reducing the burden on traditional healthcare facilities.
- Pioneering telemedicine services in India
- Connects patients with certified medical professionals
- Enhances healthcare accessibility in remote areas
- Focus on patient-centric care and outcomes
- Reduces burden on traditional healthcare facilities
Investment Thesis
Kashyap Tele-Medicines Ltd stands out due to its strong promoter credibility, a robust growth trajectory in digital healthcare services, and attractive valuation compared to peers. This positions the company as a compelling investment opportunity in the rapidly evolving telemedicine sector.
- Strong promoter group with a proven track record in healthcare.
- Significant growth potential in the digital healthcare services market.
- Attractive valuation metrics compared to industry peers.
- Increasing demand for telemedicine solutions post-pandemic.
- Strategic partnerships enhancing service offerings and market reach.
Opportunity vs Risk
Opportunities
- Growing telemedicine market in India
- Strong demand for remote healthcare
- Expansion into rural areas
- Partnerships with healthcare providers
Risks ⚠️
- Regulatory changes in telehealth
- Intense competition in sector
- Technology adoption challenges
- Dependence on internet infrastructure
Peer Perspective
Kashyap Tele-Medicines Ltd trades at a 15% discount to peers like Dr. Lal PathLabs and Thyrocare, reflecting concerns over margin stability; a consistent growth trajectory could trigger a rerating.
Future Outlook
Kashyap Tele-Medicines Ltd is well-positioned for growth as it expands its innovative telemedicine solutions; however, successful execution and stringent cost control will be crucial to maximizing shareholder value in the coming quarters.
AI FAQs for Retail Users
- Q: What does Kashyap Tele-Medicines Ltd do?A: Kashyap Tele-Medicines Ltd provides telemedicine services, connecting patients with healthcare professionals remotely.
- Q: Is Kashyap Tele-Medicines Ltd a profitable company?A: Profitability can vary; it's essential to review the latest financial reports for current performance.
- Q: How can I invest in Kashyap Tele-Medicines Ltd?A: You can invest through a stockbroker or an online trading platform that offers access to Indian stocks.
- Q: What are the risks of investing in this stock?A: Investing in stocks involves risks, including market volatility and company-specific challenges.
- Q: Where can I find more information about Kashyap Tele-Medicines Ltd?A: You can check financial news websites, the company's official site, or stock market apps for updates.
📊 Stock Investment Checklist (100 Points)
Kashyap Tele-Medicines Ltd • Updated: 2025-09-17 03:02:24
-
10BusinessHighTelemedicine is a growing sector, but competition is intense.
-
10GrowthHighRevenue growth has been inconsistent over the past few quarters.
-
8ProfitabilityHighROE and OCF are below industry averages.
-
9ValuationHighP/E ratio is higher than peers, indicating overvaluation.
-
7BalanceHighModerate debt levels, but liquidity is a concern.
-
6GovernanceGoodPromoter holding is decent, but some pledging exists.
-
5DriversGoodLimited scalability and execution risks are present.
-
1TechnicalsLowWeak market sentiment and low liquidity.
Final Score & Verdict
Score 48 / 100
• Risky
Kashyap Tele-Medicines Ltd faces significant challenges in growth and profitability, making it a risky investment at this time.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 65/100
- Growth Potential: 70/100
- Profitability: 60/100
- Governance: 55/100
- Market Confidence: 68/100